Successful multi-target therapy using corticosteroid, tacrolimus, cyclophosphamide, and rituximab for rapidly progressive interstitial lung disease in a patient with clinically amyopathic dermatomyositis

被引：13
|
作者：
Watanabe, Ryu [1 ]
Ishii, Tomonori [1 ]
Araki, Kyoko [1 ]
Ishizuka, Mariko [1 ]
Kamogawa, Yukiko [1 ]
Fujita, Yoko [1 ]
Shirota, Yuko [1 ]
Fujii, Hiroshi [1 ]
Harigae, Hideo [1 ]
机构：
[1] Tohoku Univ, Grad Sch Med, Dept Hematol & Rheumatol, Sendai, Miyagi 9808574, Japan
来源：
MODERN RHEUMATOLOGY | 2016年 / 26卷 / 03期
关键词：
Clinically amyopathic dermatomyositis; Interstitial lung disease; Multi-target therapy; Rituximab; ANTIBODY;
D O I：
10.3109/14397595.2015.1012797
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：465 / 466
页数：2
相关论文
共 50 条
  • [1] Rapidly Progressive Interstitial Lung Disease In Clinically Amyopathic Dermatomyositis
    Mangardich, A.
    Zanoria, S.
    Kanaan, J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
  • [2] Mycophenolate mofetil therapy for rapidly progressive interstitial lung disease in a patient with clinically amyopathic dermatomyositis
    Tsuchiya, Haruka
    Tsuno, Hirotaka
    Inoue, Mariko
    Takahashi, Yuko
    Amashita, Hiroyuki Y.
    Kaneko, Hiroshi
    Kano, Toshikazu
    Mimori, Akio
    MODERN RHEUMATOLOGY, 2014, 24 (04) : 694 - 696
  • [3] Rapidly progressive lung disease in a patient with signs of clinically amyopathic dermatomyositis
    Zampeli, E.
    Skopouli, F. N.
    Athanasakos, A.
    Moutsopoulos, H. M.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2017, 35 (06) : 1057 - 1058
  • [4] Rapidly Progressive Interstitial Lung Disease as the Presenting Finding in Clinically Amyopathic Dermatomyositis
    Sayad, K.
    Greer, M. K.
    Iftikhar, I. H.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [5] Fatal rapidly progressive interstitial lung disease in a patient with amyopathic dermatomyositis
    Mobeireek, Abdullah
    Conca, Walter
    Mohammed, Shamayel
    AlObaid, Fahad
    AlHajji, Mohammad
    ANNALS OF THORACIC MEDICINE, 2021, 16 (03) : 294 - 298
  • [6] AMYOPATHIC DERMATOMYOSITIS WITH RAPIDLY PROGRESSIVE INTERSTITIAL LUNG DISEASE
    Stevens, Andrew
    Orr, Lindsey
    Lazarous, Deepa
    Reichner, Cristina
    CHEST, 2020, 158 (04) : 2015A - 2015A
  • [7] Successful multi-target therapy including rituximab and mycophenolate mofetil in anti-melanoma differentiation-associated gene 5 antibody-positive rapidly progressive interstitial lung disease with clinically amyopathic dermatomyositis
    Hisanaga, Jumpei
    Kotani, Takuya
    Fujiki, Youhei
    Yoshida, Shuzo
    Takeuchi, Tohru
    Makino, Shigeki
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2017, 20 (12) : 2182 - 2185
  • [8] Pirfenidone in patients with rapidly progressive interstitial lung disease associated with clinically amyopathic dermatomyositis
    Ting Li
    Li Guo
    Zhiwei Chen
    Liyang Gu
    Fangfang Sun
    Xiaoming Tan
    Sheng Chen
    Xiaodong Wang
    Shuang Ye
    Scientific Reports, 6
  • [9] SUCCESSFUL MANAGEMENT OF CLINICALLY AMYOPATHIC HYPOMYOPATHIC DERMATOMYOSITIS WITH RAPIDLY PROGRESSIVE INTERSTITIAL LUNG DISEASE (ILD): A CASE REPORT
    Chandrasekaran, Sai Harini
    Pugazhendi, Inban
    Rameshkumar, Sai Sakthi
    Chandrasekaran, Vishnu Priya
    Srinivasan, Amitesh Krishna
    CHEST, 2024, 166 (04) : 3461A - 3462A
  • [10] Pirfenidone in patients with rapidly progressive interstitial lung disease associated with clinically amyopathic dermatomyositis
    Li, Ting
    Guo, Li
    Chen, Zhiwei
    Gu, Liyang
    Sun, Fangfang
    Tan, Xiaoming
    Chen, Sheng
    Wang, Xiaodong
    Ye, Shuang
    SCIENTIFIC REPORTS, 2016, 6
12345